Document is current
Any future updates will be listed below
-
Authors
Sekulic, Andjela
Herr, Sarah M.
Mulfaul, Kelly
Pompös, Inga-Marie
Winkler, Silvia
Dietrich, Carola
Obermayer, Benedikt
Mullins, Robert F.
Conrad, Thomas
Zipfel, Peter F.
Sennlaub, Florian
Skerka, Christine
Strauß, Olaf
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 1 April 2025
Accepted: 24 June 2025
First Online: 3 July 2025
Declarations
:
: All experimental protocols were approved by a local institutional licensing committee. After obtaining informed consent, patients’ data, blood and tissue samples were collected according to the guidelines of the local ethics committees (EA2/004/14) and according to the Guidelines of the World Medical Association Declaration of Helsinki. All animal procedures used in this study were carried out in accordance relevant guideline and regulations according to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and approved by the Landesamt für Gesundheit und Soziales, LageSo, Berlin; Licenses– T-CH 0027/20 and G0005/21 and “Comité d’éthique en expérimentation animale Charles Darwin” (Ce5/2010/013; Ce5/2011/033; Ce5/2010/044). All methods are reported with ARRIVE guidelines.
: PFZ received honoraria and speaker fees from Alexion, Alnylam, Bayer, CSL Vifor, Eleva Biologics, Novartis and Samsung Bioepis. CS consulted for ELEVA and received compensation and OS received lecture fees from Bayer AG.
